Avidity Partners Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-425,041
| Closed | -$17.8M | – | 74 |
|
|
2024
Q3 | $17.8M | Sell |
425,041
-302,496
| -42% | -$12.7M | 0.91% | 42 |
|
|
2024
Q2 | $26.5M | Buy |
727,537
+262,300
| +56% | +$9.55M | 1.13% | 38 |
|
|
2024
Q1 | $23.7M | Sell |
465,237
-1,006
| -0.2% | -$51.2K | 0.76% | 43 |
|
|
2023
Q4 | $9.04M | Buy |
+466,243
| New | +$9.04M | 0.33% | 60 |
|
|
2020
Q1 | – | Sell |
-10,500
| Closed | -$2.59M | – | 58 |
|
|
2019
Q4 | $2.59M | Buy |
+10,500
| New | +$2.59M | 1.63% | 27 |
|